Imaging mass spectrometry: Challenges in visualization of drug distribution in solid tumors

Current Opinion in Pharmacology

Volumn 13, Issue 5, 2013, Pages 807-812

  Morosi, Lavinia ^a   Zucchetti, Massimo ^a   D'Incalci, Maurizio ^a   Davoli, Enrico ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BANOXANTRONE; CYTOTOXIC AGENT; ERLOTINIB; GEFITINIB; IMATINIB; PACLITAXEL; TITANIUM DIOXIDE;

ARTICLE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TUMOR LEVEL; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; MASS SPECTROMETRY; MOLECULAR IMAGING; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84892971177     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.06.003     Document Type: Review

References (57)

1. Svatos A: Mass spectrometric imaging of small molecules. Trends Biotechnol 2010, 28: 425-434.
2. Greer T, Sturm R, Li L: Mass spectrometry imaging for drugs and metabolites. J Proteomics 2011, 74: 2617-2631.
3. Gustafsson JO, Oehler MK, Ruszkiewicz A, McColl SR, Hoffmann P: MALDI imaging mass spectrometry (MALDI-IMS)- application of spatial proteomics for ovarian cancer classification and diagnosis. Int J Mol Sci 2011, 12: 773-794.
4. Balluff B, Schone C, Hofler H, Walch A: MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications. Histochem Cell Biol 2011, 136: 227-244.
5. Schone C, Hofler H, Walch A: MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. Clin Biochem 2013, 46: 539-545.
6. Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, Guix M, Arteaga CL, Caprioli RM: Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004, 64: 9093-9100. (Pubitemid 39665523)
7. Prideaux B, Stoeckli M: Mass spectrometry imaging for drug distribution studies. J Proteomics 2012, 75: 4999-5013.
8. Pellegatti M, Pagliarusco S: Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review. Expert Opin Drug Metab Toxicol 2011, 7: 137-146.
9. Solon EG: Use of radioactive compounds and autoradiography to determine drug tissue distribution. Chem Res Toxicol 2012, 25: 543-555.
10. Saleem A, Brown GD, Brady F, Aboagye EO, Osman S, Luthra SK, Ranicar AS, Brock CS, Stevens MF, Newlands E et al.: Metabolic activation of temozolomide measured in vivo using positron emission tomography. Cancer Res 2003, 63: 2409-2415. (Pubitemid 36605177)
11. Van der Veldt AA, Lubberink M, Bahce I, Walraven M, de Boer MP, Greuter HN, Hendrikse NH, Eriksson J, Windhorst AD, Postmus PE et al.: Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. Cancer Cell 2012, 21: 82-91.
12. Hutchins GD, Miller MA, Soon VC, Receveur T: Small animal PET imaging. ILAR J 2008, 49: 54-65.
13. Grantab RH, Tannock IF: Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib. BMC Cancer 2012, 12:214.
14. Patel KJ, Tredan O, Tannock IF: Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues. Cancer Chemother Pharmacol 2013 http://dx.doi.org/10.1007/s00280-013-2176-z.
15. Goto-Inoue N, Hayasaka T, Zaima N, Nakajima K, Holleran WM, Sano S, Uchida Y, Setou M: Imaging mass spectrometry visualizes ceramides and the pathogenesis of dorfman- chanarin syndrome due to ceramide metabolic abnormality in the skin. PLoS ONE 2012, 7:e49519.
16. Seeley EH, Schwamborn K, Caprioli RM: Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem 2011, 286: 25459-25466.
17. Schwamborn K, Caprioli RM: MALDI imaging mass spectrometry - painting molecular pictures. Mol Oncol 2010, 4: 529-538.
18. Vismeh R, Waldon DJ, Teffera Y, Zhao Z: Localization and quantification of drugs in animal tissues by use of desorption electrospray ionization mass spectrometry imaging. Anal Chem 2012, 84: 5439-5445.
19. Wiseman JM, Ifa DR, Zhu Y, Kissinger CB, Manicke NE, Kissinger PT, Cooks RG: Desorption electrospray ionization mass spectrometry: imaging drugs and metabolites in tissues. Proc Natl Acad Sci U S A 2008, 105: 18120-18125.
20. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P et al.: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366: 883-892.
21. Jones EA, Schmitz N, Waaijer CJ, Frese CK, van Remoortere A, van Zeijl RJ, Heck AJ, Hogendoorn PC, Deelder AM, Altelaar AF et al.: Imaging mass spectrometry-based molecular histology differentiates microscopically identical and heterogeneous tumors. J Proteome Res 2013 http://dx.doi.org/10.1021/ pr301190g.
22. Amstalden van Hove ER, Blackwell TR, Klinkert I, Eijkel GB, Heeren RM, Glunde K: Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res 2010, 70: 9012-9021.
23. Saggar JK, Fung AS, Patel KJ, Tannock IF: Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors. Mol Cancer Ther 2013, 12: 542-552.
24. Steven RT, Bunch J: Repeat MALDI MS imaging of a single tissue section using multiple matrices and tissue washes. Anal Bioanal Chem 2013, 405: 4719-4728.
25. Thurber GM, Weissleder R: A systems approach for tumor pharmacokinetics. PLoS ONE 2011, 6:e24696.
26. Minchinton AI, Tannock IF: Drug penetration in solid tumours. Nat Rev Cancer 2006, 6: 583-592. (Pubitemid 44140857)
27. Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307: 58-62. (Pubitemid 40093472)
28. Matsumoto S, Batra S, Saito K, Yasui H, Choudhuri R, Gadisetti C, Subramanian S, Devasahayam N, Munasinghe JP, Mitchell JB et al.: Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 2011, 71: 6350-6359.
29. Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, Ancukiewicz M, Wang M, Wen PY, Ivy P, Batchelor TT et al.: Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res 2012, 72: 402-407.
30. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK: Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000, 60: 4324-4327. (Pubitemid 32103603)
31. Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF: The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005, 11: 8782-8788. (Pubitemid 43005929)
32. Choi J, Credit K, Henderson K, Deverkadra R, He Z, Wiig H, Vanpelt H, Flessner MF: Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration. Clin Cancer Res 2006, 12: 1906-1912.
33. Bello E, Taraboletti G, Colella G, Zucchetti M, Forestieri D, Licandro SA, Berndt A, Richter P, D'Incalci M, Cavalletti E et al.: The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts. Mol Cancer Ther 2013, 12: 131-140.
34. Grossman R, Tyler B, Rudek MA, Kim E, Zadnik P, Khan U, Blakeley JO, Pathak AP, Brem H: Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model. Cancer Chemother Pharmacol 2013 http://dx.doi.org/10.1007/ s00280-013-2172-3.
35. Cesca M, Frapolli R, Berndt A, Scarlato V, Richter P, Kosmehl H, D'Incalci M, Ryan AJ, Giavazzi R: The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma. Neoplasia 2009, 11: 1155-1164.
36. Chughtai K, Heeren RM: Mass spectrometric imaging for biomedical tissue analysis. Chem Rev 2012, 110: 3237-3277.
37. Steven RT, Race AM, Bunch J: Para-nitroaniline is a promising matrix for MALDI-MS imaging on intermediate pressure ms systems. J Am Soc Mass Spectrom 2013, 24: 801-804.
38. Carra A, Falciola L, Cappelletti G, Davoli E: Molecular imaging of trace compounds embedded on human skin by mass spectrometry. In ASMS 60th Annual Conference Proceedings. 2012:1549.
39. Castellino S, Groseclose MR, Wagner D: MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis 2011, 3: 2427-2441.
40. Troendle FJRC, Yost RA: Detection of pharmaceutical compounds in tissue by matrix-assisted laser desorption/ionization and laser desorption/chemical ionization tandem mass spectrometry with a quadrupole ion trap. J Am Soc Mass Spectrom 1999, 10: 1315-1321. (Pubitemid 34506457)
41. Cornett DS, Frappier SL, Caprioli RM: MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal Chem 2008, 80: 5648-5653.
42. Atkinson SJ, Loadman PM, Sutton C, Patterson LH, Clench MR: Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom 2007, 21: 1271-1276. (Pubitemid 46509403)
43. Huamani J, Willey C, Thotala D, Niermann KJ, Reyzer M, Leavitt L, Jones C, Fleishcher A, Caprioli R, Hallahan DE et al.: Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models. Int J Radiat Oncol Biol Phys 2008, 71: 237-246.
44. Marko-Varga G, Fehniger TE, Rezeli M, Dome B, Laurell T, Vegvari A: Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. J Proteomics 2011, 74: 982-992.
45. Fehniger TE, Vegvari A, Rezeli M, Prikk K, Ross P, Dahlback M, Edula G, Sepper R, Marko-Varga G: Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem 2011, 83: 8329-8336.
46. Marko-Varga G, Vegvari A, Rezeli M, Prikk K, Ross P, Dahlback M, Edula G, Sepper R, Fehniger TE: Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine. Clin Transl Med 2013, 1:8.
47. van Kampen JJ, Burgers PC, de Groot R, Gruters RA, Luider TM: Biomedical application of MALDI mass spectrometry for small-molecule analysis. Mass Spectrom Rev 2010, 30: 101-120.
48. Wei J, Buriak JM, Siuzdak G: Desorption-ionization mass spectrometry on porous silicon. Nature 1999, 399: 243-246. (Pubitemid 29246449)
49. Northen TR, Yanes O, Northen MT, Marrinucci D, Uritboonthai W, Apon J, Golledge SL, Nordstrom A, Siuzdak G: Clathrate nanostructures for mass spectrometry. Nature 2007, 449: 1033-1036. (Pubitemid 350017585)
50. Lee JH, Choi HS, Nasr KA, Ha M, Kim Y, Frangioni JV: High-throughput small molecule identification using MALDI-TOF and a nanolayered substrate. Anal Chem 2011, 83: 5283-5289.
51. Tata A, Fernandes AM, Santos VG, Alberici RM, Araldi D, Parada CA, Braguini W, Veronez L, Silva Bisson G, Reis FH et al.: Nanoassisted laser desorption-ionization-MS imaging of tumors. Anal Chem 2012, 84: 6341-6345.
52. Taira S, Sugiura Y, Moritake S, Shimma S, Ichiyanagi Y, Setou M: Nanoparticle-assisted laser desorption/ionization based mass imaging with cellular resolution. Anal Chem 2008, 80: 4761-4766. (Pubitemid 351842357)
53. Shrivas K, Hayasaka T, Sugiura Y, Setou M: Method for simultaneous imaging of endogenous low molecular weight metabolites in mouse brain using TiO2 nanoparticles in nanoparticle-assisted laser desorption/ionization-imaging mass spectrometry. Anal Chem 2011, 83: 7283-7289.
54. Dupre M, Cantel S, Durand JO, Martinez J, Enjalbal C: Silica nanoparticles pre-spotted onto target plate for laser desorption/ionization mass spectrometry analyses of peptides. Anal Chim Acta 2012, 741: 47-57.
55. Alexandrov T: MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinformatics 2012, 13(Suppl 16):S11.
56. Fonville JM, Carter C, Cloarec O, Nicholson JK, Lindon JC, Bunch J, Holmes E: Robust data processing and normalization strategy for MALDI mass spectrometric imaging. Anal Chem 2012, 84: 1310-1319.
57. Palmer AD, Bunch J, Styles IB: Randomised approximation methods for the efficient compression and analysis of hyperspectral data. Anal Chem 2013 http://dx.doi.org/10.1021/ac400184g.